Wickliffe-based Lubrizol Corp. has acquired Bavaria Medizin Technologie GmbH in Germany.
Bavaria Medizin Technologie makes intravascular and nonvascular devices like drug-coated balloons, according to a news release. The company offers original equipment manufacturing services and private label manufacturing of proprietary catheters and balloons. It’s headquartered near Munich, Germany, and also has a manufacturing site in Sibiu, Romania. It has more than 100 employees.
Lubrizol has about 8,700 employees across the globe and had $6.8 billion in revenues in 2018.
The acquisition was made by Lubrizol’s German subsidiary Lubrizol Deutschland GmbH. It purchased Bavaria Medizin Technologie from majority shareholder Custos Vermögensverwaltungs GmbH and minority shareholders, the release stated. Terms of the acquisition are not being disclosed.
By Rachel Abbey McCafferty
Source: Crain’s Cleveland Business
CF Industries Holdings, Inc. (NYSE: CF) today announced that it has closed its acquisition of Incitec Pivot Limited’s (“IPL”) ammonia production complex located in Waggaman, Louisiana. Under the terms of the agreement, CF Industries purchased the Waggaman ammonia plant and related assets for $1.675 billion, subject to adjustments.
The Virgin Atlantic flight was powered entirely by SAF, that was a drop-in replacement for conventional jet fuel, but made solely from sustainable feedstocks. This was enabled through the inclusion of a new bio-based aromatic jet fuel blending component.
Cepsa SA (Madrid) has agreed a deal with C2X, an independent firm owned by AP Moller Holding with AP Moller-Maersk as minority owner, to develop a 300,000 metric tons per year renewable methanol plant at Huelva, Spain.